EH

Encompass Health Corporation

EHCHealthcareNASDAQ

Medical Care Facilities · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.94B
+10.5% YoY
Net Income
$566.2M
+24.2% YoY
EBITDA
$1.40B
+18.3% YoY
Free Cash Flow
$284.1M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 79.5, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 83.0, above 70, stock may be overbought
About Encompass Health Corporation

Part of the healthcare sector, Encompass Health Corporation (EHC) is listed under Medical Care Facilities. The company carries a $11.13B market cap, placing it firmly in the large-cap category. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Key stats
Market Cap$11.13B
P/E (TTM)19.21
Fwd P/E17.17
EPS$5.84
Beta0.60
52W Change+2.0%
Dividend Yield0.68%
ROE25.2%
Analysis

The company holds $110.5M in cash, though total debt stands at $2.79B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $284.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 25.2%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 9.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $4.35B (2022) to $5.94B (2025), reflecting a 36% increase over the period.

EHC's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Encompass Health Corporation and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms